Health DiagnosticsProcess AutomationArtificial IntelligenceBiomedical EngineeringGeneticsDetectors, Sensors and MemsLife ScienceMedical
Description
Danaher Corporation (Danaher) operates as a global science and technology innovator committed to accelerating the power of science and technology to improve human health.
Danaher operates through more than 15 operating companies with leadership posi…
Analysis
Middle-of-the-road
Danaher Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.
On valuation, the picture is expensive. The owner-earnings multiple stands at 25.4×; owner earnings: the cash an owner could take out each year. The implied growth embedded in that price is around 9% a year, against analyst forecasts of 9%. The price, in other words, assumes less than the experts do.
Growth is moderate; the safety picture is sturdy. The company scores 8/20 on our value-creation score: creating some value.
Flags to be aware of: A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202397
83
2023202420252026
All-time high
98
Feb 2026
All-time low
14
Jan 2024
Average rank
80
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
36
22
17
50
Price/Earnings
39
44
35
45
Price/Book
64
61
50
48
Dividend Yield
95
93
88
84
Value (overall)
87
75
61
87
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.